Position
Chief Executive Officer
Company
Laverock Therapeutics
Description
Laverock Therapeutics announces the appointment of Parker Moss as Chief Executive Officer and Paul J. Sekhri as Executive Chairman. They will guide the company through its transition into a clinical-stage biotech firm.
Quick answer
Laverock Therapeutics Appoints Parker Moss as Chief Executive Officer (November 16, 2026). Laverock Therapeutics is based in London, England, United Kingdom.
- Who is the new Chief Executive Officer at Laverock Therapeutics?
- Laverock Therapeutics named Parker Moss Chief Executive Officer, announced November 16, 2026.
- What did Laverock Therapeutics announce on November 16, 2026?
- Laverock Therapeutics announces the appointment of Parker Moss as Chief Executive Officer and Paul J. Sekhri as Executive Chairman. They will guide the company through its transition into a clinical-stage biotech firm.
- What does Laverock Therapeutics do?
- Laverock Therapeutics is a gene-silencing company with a uniquely powerful technology harnessing the cell’s natural gene regulatory mechanisms to develop programmable advanced therapies.
- Where is Laverock Therapeutics based?
- Laverock Therapeutics is based in London, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- FrostPharma (November 16, 2026), RELMADA THERAPEUTICS, INC. (November 16, 2026), I-MED Radiology Network (November 16, 2026) and GoGoMeds (November 15, 2026) also announced leadership changes within 45 days of Laverock Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- FrostPharma Appoints Pia Renaudin as CEO (November 16, 2026)
- Relmada Therapeutics Appoints Jørn Skibsted Jakobsen as Chief Development Officer (November 16, 2026)
- I-MED Radiology Network Appoints Natasha Toohey as Chief Executive Officer (November 16, 2026)
- GoGoMeds Appoints Harish Panchal as Chief Executive Officer (November 15, 2026)
- Bristol Myers Squibb Appoints Cristian Massacesi as Head of R&D (November 15, 2026)
- Kingdom University Hospital Appoints Professor Abdelghani Tbakhi as Chief Medical Officer and Chief Quality Officer (November 15, 2026)
Who to call at Laverock Therapeutics, and when
A new leader at Laverock Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Laverock Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Laverock Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Laverock Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Laverock Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Laverock Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.